TEP/TDM et cancer pulmonaire : indications et perspectives |
| |
| Authors: | G. Quéré R. Abgral X. Palard R. Descourt E. Noel Savina S. Querellou E. Le Fur P.Y. Salaün |
| |
| Affiliation: | 1. Institut de cancérologie et d’hématologie, hôpital Morvan, hôpital de la Cavale Blanche, CHRU de Brest, 2, avenue Foch, 29200 Brest, France;2. Service de médecine nucléaire, CHRU de Brest, 29200 Brest, France;3. Université européenne de Bretagne, université de Brest, 29200 Brest, France;4. Service de radiothérapie, institut de cancérologie et d’hématologie, hôpital Morvan, CHRU de Brest, 29200 Brest, France;5. Département de médecine interne et pneumologie, hôpital de la Cavale Blanche, CHRU de Brest, 29200 Brest, France;1. Service de médecine nucléaire, hôpital Ibn Sina, CHIS, rue Lamfadel Cherkaoui, BP 6527, Rabat, Maroc;2. Université MedV, Suissi, Rabat, Maroc;1. Service de radiologie, centre hospitalo-universitaire de Yopougon, 21 BP, 632 Abidjan 21, Côte d’Ivoire;2. Service d’imagerie pédiatrique, centre hospitalo-universitaire de Rennes, hôpital Sud, 16, boulevard de Bulgarie, BP 90, 347–35203 Rennes cedex 2, France;3. Service de biophysique et de médecine nucléaire, centre hospitalo-universitaire de Cocody, BP V 166, Abidjan, Côte d’Ivoire;1. Service de médecine nucléaire, hôpital Foch, 40, rue Worth, 92151 Suresnes, France;2. Service de médecine nucléaire, hôpital Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France;1. Service de médecine nucléaire, groupe hospitalier Pitié-Salpêtrière, 83, boulevard de l’Hôpital, 75013 Paris, France;2. UMR_S 678, université Pierre-et-Marie-Curie, 91, boulevard de l’Hôpital, 75013 Paris, France;3. Service de radiologie, HIA du Val-de-Grâce, 74, boulevard de Port-Royal, 75005 Paris, France;4. Service de pharmacologie, département des maladies du système nerveux, hôpital Pitié-Salpêtrière, AP–HP, 75013 Paris, France |
| |
| Abstract: | Lung cancer is a major public health problem that generates a large number of imaging and acts for diagnostic procedures. The last decade saw the development of positron emission tomography coupled to the scanner (PET/CT), which has significantly improved the staging and allowed to obtain better accuracy in the initial staging. It may change the management of a patient thanks to a better characterization of the initial situation. Several series have to assess performance, often higher than that of CT and there are several recommendations specifying the place of this examination in the management of lung cancer. It also seems to become a complementary tool to the radiotherapist for delineation of volumes to be irradiated using functional information of the tumor. The concept of biological target volume (BTV) has been introduced. There are more perspectives for diagnostic, therapeutic evaluation and prognosis with the study of new tracers, including those of hypoxia and cell proliferation. |
| |
| Keywords: | Lung cancer Staging PET/CT Perspectives |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
